Gold prices dip as hawkish Fed minutes weigh ahead of Jackson Hole
Philip A. Laskawy, a director at Henry Schein Inc. (NASDAQ:HSIC), a prominent healthcare provider with an $8.76 billion market cap, recently sold 2,604 shares of the company’s common stock. The shares were sold at an average price of $71.044 per share, resulting in a total transaction value of approximately $184,998. According to InvestingPro data, the stock has shown low price volatility and currently trades near its Fair Value. Following this sale, Laskawy holds 24,805 shares directly. The transaction took place on March 19, 2025, as disclosed in a recent SEC filing. While this insider sale occurred, InvestingPro analysis reveals management has been actively buying back shares, with analyst targets ranging from $55 to $90 per share. Get deeper insights into insider trading patterns and 7 additional ProTips with an InvestingPro subscription.
In other recent news, Henry Schein Inc. reported its Q4 2024 earnings, which revealed a miss in both earnings per share (EPS) and revenue compared to market forecasts. The company’s EPS was $1.19, falling short of the anticipated $1.23, and its revenue reached $3.19 billion, below the forecasted $3.35 billion. Despite this, the company demonstrated a year-over-year revenue growth of 5.8%, with global sales totaling $3.2 billion. The company continues to focus on high-growth, high-margin businesses, which contributed significantly to its operating income for the year. In a separate development, Henry Schein announced a change in its executive team, as President James P. Breslawski will step down in April 2025 to become a Senior Advisor, though details on his successor remain undisclosed. Additionally, Henry Schein has engaged in strategic initiatives, including product innovation and strategic acquisitions, to drive future growth. Looking ahead, the company projects a total sales growth of 2-4% for 2025, with non-GAAP diluted EPS expected to range between $4.80 and $4.94. Investors and stakeholders may watch for further announcements regarding these developments.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.